Xuzhou, China Clinical Trials

A listing of Xuzhou, China clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 81 clinical trials
Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes

Liraglutide injection is a glucagon-like peptide-1 (GLP-1) analogue that activates the cyclic adenosine monophosphate (cAMP) and mitogen-activated protein kinase (MAPK) pathway by binding to the GLP-1 receptor (GLP-1R),thus,it has physiological effects such as glucose-dependent insulin synthesis and secretion, inhibition of -cell apoptosis, promotion of -cell proliferation and regeneration, inhibition of …

body mass index
glucagon
liraglutide
glucagon-like peptide-1
hemoglobin a1c
Xuzhou Third People's Hospital
 (6.1 away) Contact site
  • 0 views
  • 25 Jan, 2021
  • +45 other locations
A Clinical Study to Evaluate Pharmacokinetics Safety and Tolerability of Abexinostat in Chinese Patients

This is an open-label, non-randomized clinical study to evaluate the pharmacokinetic (PK) profiles, safety, tolerability and preliminary efficacy of oral abexinostat monotherapy in patients with non-Hodgkin's lymphoma who have failed standard of care, and thereby to determine the pharmacokinetic (PK) parameters, the maximum tolerated dose (MTD), and the recommended phase …

blood transfusion
hodgkin's disease
The Affiliated Hospital of Xuzhou Medical University
 (7.5 away) Contact site
  • 2 views
  • 19 May, 2021
  • +3 other locations
A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer

This is a randomized, double-blind, multicenter phase III clinical study to evaluate efficacy and safety of anlotinib hydrochloride capsule combined with chemotherapy versus placebo combined with chemotherapy as first-line treatment in subjects with advanced non-squamous cell non-small cell lung cancer.

The Affiliated Hospital of Xuzhou Medical University
 (6.5 away) Contact site
  • 0 views
  • 25 Jan, 2021
  • +57 other locations
Clinical Efficacy and Safety of a Prospective Multicenter Drug Coated Balloon for Left Main Artery Disease in China

This is a prospective and observational study. Patients with primary mediana 010 or 001 left main bifurcation lesions were treated with drug ball coated balloon from November 2018 to November 2020 in four hospitals in Huaihai area. The clinical characteristics, pathological changes, operation process and perioperative drug treatment data were …

Xuzhou third people's hospital
 (6.1 away) Contact site
  • 0 views
  • 26 Jan, 2021
  • 1 location
A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Beh et Disease

This is a phase 2, multi-center, randomized, placebo-controlled, double-blind, parallel-group study with an equal randomization among the Hemay005 high dose, lower dose and placebo treatment groups. After subject randomization, each subject will enter an core-treatment Phase for 12 weeks following an extended-treatment phase for another 12weeks and a follow up …

Linyi People's Hospital
 (84.6 away) Contact site
  • 0 views
  • 27 Jan, 2021
  • +30 other locations
Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D

The purpose of this study is to generate effectiveness data of ARNI, in the Chinese HFrEF patients with implanted ICD or CRT-D. This will be a multicenter, interventional, open-label, and prospective single-arm study to evaluate the effect of ARNI on VAs in approximately 275 HFrEF patients receiving ICD or CRT-D …

angiotensin ii receptor antagonists
Novartis Investigative Site
 (6.5 away) Contact site
  • 0 views
  • 01 Apr, 2021
  • +15 other locations
A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy

Primary Objective: To demonstrate the superiority of the single pill combination (SPC) ezetimibe 10 mg/rosuvastatin 10 mg (E10/R10) compared to rosuvastatin 10 mg (R10), in the reduction of low density lipoprotein cholesterol (LDL-C) after 8 weeks. Secondary Objectives: To evaluate the proportion of patients who attain their LDL-C goal. To …

Investigational Site Number 1560003
 (8.9 away) Contact site
  • 0 views
  • 12 Mar, 2021
  • +11 other locations
Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A

The primary objectives of the study are to further evaluate the efficacy and safety of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection (FRSW107) in adolescent and adult patients with hemophilia A.

The Affiliated Hospital of Xuzhou Medical College
 (6.1 away) Contact site
  • 0 views
  • 26 Apr, 2021
  • +15 other locations
A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer

Based on indicators such as 24 week progression free survival (24 weeks PFS) in small cell lung cancer (SCLC) patients without disease progression after first-line platinum containing chemotherapy, objective response rate (ORR) in SCLC patients with recurrence or progression after first-line platinum containing chemotherapy, and orr in SCLC patients with …

etoposide
topotecan
vinorelbine
alopecia
cancer chemotherapy
General hospital of eastern theater command
 (171.5 away) Contact site
  • 0 views
  • 28 May, 2021
  • +8 other locations
Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma

A Regional, Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Severe Uncontrolled Asthma

albuterol
fluticasone
Research Site
 (7.5 away) Contact site
  • 29 views
  • 22 Jun, 2021
  • +55 other locations